These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 11155837)

  • 1. Can economic evaluation guidelines improve efficiency in resource allocation? The cases of Portugal, The Netherlands, Finland, and the United Kingdom.
    Kanavos P; Trueman P; Bosilevac A
    Int J Technol Assess Health Care; 2000; 16(4):1179-92. PubMed ID: 11155837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of health care and policymaking.
    Johannesson M
    Health Policy; 1995 Sep; 33(3):179-90. PubMed ID: 10145120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health economic evaluations in reimbursement decision making in the Netherlands: time to take it seriously?
    Franken M; Koopmanschap M; Steenhoek A
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):383-9. PubMed ID: 25444296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of economic evaluation in the pricing and reimbursement of medicines.
    Drummond M; Jönsson B; Rutten F
    Health Policy; 1997 Jun; 40(3):199-215. PubMed ID: 10168752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical review of health-related economic evaluations in Australia: implications for health policy.
    Salkeld G; Davey P; Arnolda G
    Health Policy; 1995 Feb; 31(2):111-25. PubMed ID: 10141252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation in support of national health policy: the case of The Netherlands.
    Elsinga E; Rutten FF
    Soc Sci Med; 1997 Aug; 45(4):605-20. PubMed ID: 9226785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of economic evaluation in health care: Australian decision makers' perceptions.
    Ross J
    Health Policy; 1995 Feb; 31(2):103-10. PubMed ID: 10141251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationing health care: from needs to markets? The politics of destruction: rationing in the UK health care market.
    Pollock AM
    Health Care Anal; 1995 Nov; 3(4):299-308; discussion 309-14. PubMed ID: 10156208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of NICE technology appraisal in NHS rationing.
    Walker S; Palmer S; Sculpher M
    Br Med Bull; 2007; 81-82():51-64. PubMed ID: 17409119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evaluation of lifestyle interventions in the Netherlands.
    Rappange DR; Brouwer WB
    Health Econ Policy Law; 2012 Apr; 7(2):243-61. PubMed ID: 22380875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty years of using economic evaluations for drug reimbursement decisions: what has been achieved?
    Drummond M
    J Health Polit Policy Law; 2013 Dec; 38(6):1081-102. PubMed ID: 23974475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation and health care decision-making.
    Rutten F
    Health Policy; 1996 Jun; 36(3):215-29. PubMed ID: 10158267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of nursing workforce policies in five European countries: Denmark, Finland, Ireland, Portugal and United Kingdom*/England.
    Attree M; Flinkman M; Howley B; Lakanmaa RL; Lima-Basto M; Uhrenfeldt L
    J Nurs Manag; 2011 Sep; 19(6):786-802. PubMed ID: 21899632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health Economics as Rhetoric: The Limited Impact of Health Economics on Funding Decisions in Four European Countries.
    Franken M; Heintz E; Gerber-Grote A; Raftery J
    Value Health; 2016 Dec; 19(8):951-956. PubMed ID: 27987645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmaco-economic evaluations of new drugs: potential key to a more efficient allocation of the health care budget].
    Delwel GO; Sprenger MJ
    Ned Tijdschr Geneeskd; 2002 Jun; 146(23):1068-71. PubMed ID: 12085554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resource allocation and economic evaluation in Australia's healthcare system.
    Baghbanian A; Hughes I; Khavarpour FA
    Aust Health Rev; 2011 Aug; 35(3):278-83. PubMed ID: 21871187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling the resource implications and budget impact of new reimbursement guidelines for the management of cow milk allergy in Finland.
    Guest JF; Valovirta E
    Curr Med Res Opin; 2008 Apr; 24(4):1167-77. PubMed ID: 18341760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NICE methodological guidelines and decision making in the National Health Service in England and Wales.
    Gafni A; Birch S; ;
    Pharmacoeconomics; 2003; 21(3):149-57. PubMed ID: 12558466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pharmaceutical policy interventions on utilization of antipsychotic medicines in Finland and Portugal in times of economic recession: interrupted time series analyses.
    Leopold C; Zhang F; Mantel-Teeuwisse AK; Vogler S; Valkova S; Ross-Degnan D; Wagner AK
    Int J Equity Health; 2014 Jul; 13():53. PubMed ID: 25062657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the limited impact of economic evaluation in health care resource allocation: a conceptual framework.
    Williams I; Bryan S
    Health Policy; 2007 Jan; 80(1):135-43. PubMed ID: 16621124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.